Vivos (RDGL) Share-based Compensation Growth (1y) (2011 - 2025)
Powered by 
Analysis
Vivos (RDGL) Share-based Compensation Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 18.31% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 314.20% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 45.35% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -78.13% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -15.28% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 12.53% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 10.53% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -13.91% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 7.56% |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 16.16% |
| Sep 30, 2025 | -80.97% |
| Jun 30, 2025 | 24.99% |
| Mar 31, 2025 | -50.56% |
| Mar 31, 2018 | -98.41% |
| Dec 31, 2017 | 101.98% |
| Sep 30, 2017 | -11.46% |
| Jun 30, 2017 | -95.37% |
| Mar 31, 2015 | 161.47% |
| Dec 31, 2014 | 373.77% |
| Sep 30, 2014 | -16.92% |
| Mar 31, 2014 | 39.74% |
| Dec 31, 2013 | -77.27% |
| Sep 30, 2013 | -99.17% |
| Jun 30, 2013 | 46.08% |
| Mar 31, 2013 | -97.83% |
| Dec 31, 2012 | 327.66% |
| Mar 31, 2012 | 1,895.24% |
| Dec 31, 2011 | -31.13% |